You have 9 free searches left this month | for more free features.

Condition

Colorectal Cancer (2)

Metastatic Castration-resistant Prostate Cancer (2)

Renal Cell Carcinoma (2)

Urothelial Carcinoma (2)

Hormone Receptor Positive Breast Carcinoma (1)

Neoplasm Malignant (1)

Non-Clear Cell Renal Cell Carcinoma (1)

Solid Tumor (1)

Overall Status

Recruiting (4)

Sign in for free

Phase

phase 1 (2)

phase 3 (2)

Sponsor

Exelixis (4)

Collaborator

Intervention

xl092 (4)

atezolizumab (2)

nivolumab (2)

avelumab (1)

bempegaldesleukin (1)

ipilimumab (1)

regorafenib (1)

sunitinib malate (1)

Study Documents

Intervention Type

drug (4)

Funder Type

Industry (4)

Study Type

Interventional (4)

xl092

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Non-Clear Cell Renal Cell Carcinoma Trial in Duarte (XL092, Nivolumab, Sunitinib Malate)

Recruiting

Non-Clear Cell Renal Cell Carcinoma

XL092
+2 more

Duarte, California

Exelixis Clinical Site #1

Jan 13, 2023

Colorectal Cancer Trial in Omaha (XL092, Atezolizumab, Regorafenib)

Recruiting

Colorectal Cancer

XL092
+2 more

Omaha, Nebraska

Exelixis Clinical Site #1

Jul 26, 2022

Renal Cell Carcinoma, Metastatic Castration-resistant Prostate Cancer, Urothelial Carcinoma Trial in United States (XL092,

Recruiting

Renal Cell Carcinoma
+3 more

XL092
+3 more

Tucson, Arizona
+3 more

Mar 30, 2022

Tumor Malignant, Renal Cell Carcinoma, Hormone Receptor Positive Breast Carcinoma Trial in Worldwide (XL092, Atezolizumab,

Recruiting

Neoplasm Malignant
+5 more

XL092
+2 more

Duarte, California
+55 more

Aug 17, 2022